About Event

Welcome to the 2nd Neuro-Immunology Drug Development Summit

The Industry’s Definitive Digital Event Specifically Designed to Overcome the Translational Challenges of Neuroimmunological Drug Development

Focused on neurodegenerative diseases such as Parkinson’s, Alzheimer’s and ALS, and with expert industry speakers from leading drug developers including Biogen Alector, Denali and Merck, the 2nd Annual Neuroimmunology Drug Development Summit, will enable you to:

Untitled design (1)

Discover the latest advances in recapitulating human microglia in preclinical models to reduce the translational gap

Untitled design (1)

Hear about the successful investment strategies helping small biotechs to pursue novel targets

Untitled design (1)

Discuss how to approach neuroimmunological targets to improve the efficacy of neurodegenerative therapeutics

Untitled design (1)

Review the latest clinical data with neuroimmunological candidates to inform future research

Untitled design (1)

Virtually network with the leading organizations on the cutting-edge of this exciting and fast-moving space to create opportunities for future collaborations

Don’t miss this exclusive content from the comfort of your own home, download the full digital event guide here to view the full list of speakers taking part in the digital event.